Side-by-side comparison of AI visibility scores, market position, and capabilities
NYC YC W21 teen and young adult investing education app at $3.5M ARR with 2M users and 10M+ lessons; $4.4M seed with 60+ modules and fractional stock/ETF/crypto trading competing with Greenlight and Acorns for Gen Z financial literacy and first investing.
Bloom is a New York-based investing education and fractional trading app for teenagers and young adults — backed by Y Combinator (W21) with $4.4 million in total funding including $3.3 million from investors in 2022 — providing users aged 13-17 and young adults with commission-free fractional trading in stocks, ETFs, and crypto combined with 60+ structured financial education modules and a gamified learning experience that has delivered over 10 million lessons since launching in April 2022, achieving $3.5 million ARR with 2 million users. Founded in 2021 by Allan Maman, Sonny Mo, and Sam Yang, Bloom serves Generation Z's interest in building wealth and financial literacy at an age when compounding investment returns are most powerful.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.